This narrative review describes the pathophysiology, multifactorial nature, biomarker roles, and management of right ventricular dysfunction in patients with sepsis.
This narrative review highlights the pathophysiology, prognostic role, and management of right ventricular dysfunction in sepsis, an area with relatively scarce literature compared to left ventricular dysfunction.
ABSTRACT: Sepsis is a multisystem disease process, which constitutes a significant public health challenge and is associated with high morbidity and mortality. Among other systems, sepsis is known to affect the cardiovascular system, which may manifest as myocardial injury, arrhythmias, refractory shock, and/or septic cardiomyopathy. Septic cardiomyopathy is defined as the reversible systolic and/or diastolic dysfunction of one or both ventricles. Left ventricle dysfunction has been extensively studied in the past, and its prognostic role in patients with sepsis is well documented. However, there is relatively scarce literature on right ventricle (RV) dysfunction and its role. Given the importance of timely detection of septic cardiomyopathy and its bearing on prognosis of patients, the role of RV dysfunction has come into renewed focus. Hence, through this review, we sought to describe the pathophysiology of RV dysfunction in sepsis and what have we learnt so far about its multifactorial nature. We also elucidate the roles of different biomarkers for its detection and prognosis, along with appropriate management of such patient population.
Bansal et al. (Tue,) conducted a review in Sepsis. Right ventricular dysfunction was evaluated. This narrative review describes the pathophysiology, multifactorial nature, biomarker roles, and management of right ventricular dysfunction in patients with sepsis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: